FindTrial
Sign In

fezolinetant - reference formulation

DRUG2 trials

Sponsors

Astellas Pharma Global Development, Inc., Shehzad Basaria, M.D.

Conditions

Androgen Ablative Therapy of Advanced Hormone-dependent Prostate CarcinomaAndrogen Deprivation TherapyAndrogen-deprivation TherapyHealthy VolunteersHot FlashesHot FlushesHot Flushes and/or SweatsProstate Adenocarcinoma

Phase 1

A Study to Assess Bioequivalence of Fezolinetant Formulations in Healthy Female Participants
CompletedNCT04277624
Astellas Pharma Global Development, Inc.Healthy Volunteers
Start: 2020-02-20End: 2021-02-26Updated: 2024-10-18

Phase 2

Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy
RecruitingNCT06957691
Shehzad Basaria, M.D.Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma, Androgen-deprivation Therapy, Androgen Deprivation Therapy +16
Start: 2026-01-14End: 2028-12-31Target: 60Updated: 2026-08-17